Novanta Inc
NOVT
Market Cap$4.34B
Close$
$72.63
39.8% downside
Current Fair Value
39.8% downsideOvervalued by 39.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $4.34 Billion |
|---|---|
| Enterprise Value | $4.70 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $1.78 |
| Beta | 1.46 |
| Outstanding Shares | 36,024,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 61.5 |
|---|---|
| PEG | 138.18 |
| Price to Sales | 4.64 |
| Price to Book Ratio | 5.74 |
| Enterprise Value to Revenue | 4.94 |
| Enterprise Value to EBIT | 45.03 |
| Enterprise Value to Net Income | 66 |
| Total Debt to Enterprise | 0.1 |
| Debt to Equity | 0.61 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Novanta Inc
Novanta is a leading global supplier of core technology solutions that give medical and advanced industrial original equipment manufacturers ('OEMs') a competitive advantage. Novanta combines deep proprietary technology expertise and com...